Maria D. Lucas-De

Malaga, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Comment on Hong et al. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. Diabetes Care 2025;48:1728-1736.

Comment on Hong et al. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. Diabetes Care 2025;48:1728-1736.

Journal: Diabetes care
Published: May 20, 2026

Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).

Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).

Journal: Nutrients
Published: July 04, 2024

Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction.

Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction.

Journal: Revista espanola de cardiologia (English ed.)
Published: November 08, 2023

Results of semaglutide in patients older than 70 years, a real-world study of efficacy and safety.

Results of semaglutide in patients older than 70 years, a real-world study of efficacy and safety.

Journal: Minerva endocrinology
Published: June 20, 2023

Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.

Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.

Journal: Frontiers in endocrinology
Published: June 14, 2023

Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study.

Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study.

Journal: Archives of medical research
Published: April 03, 2023

Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus.

Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus.

Journal: Journal of clinical medicine
Published: November 25, 2022

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain.

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain.

Journal: Frontiers in endocrinology
Published: July 16, 2022

Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.

Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.

Journal: Clinical kidney journal
Published: January 12, 2022

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice.

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice.

Journal: Frontiers in endocrinology
Published: January 08, 2022

The value of telephone consultations during COVID-19 pandemic. An observational study.

The value of telephone consultations during COVID-19 pandemic. An observational study.

Journal: QJM : monthly journal of the Association of Physicians
Published: December 08, 2020

Woman and diabetes mellitus.

Woman and diabetes mellitus.

Journal: Medicina clinica
Published: November 04, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026